Quarterly Earnings Forecast ; Fiscal Quarter End. Consensus EPS* Forecast. High EPS* Forecast ; Sep ; Dec ; Mar Find the latest Gilead Sciences Inc (GILD) stock forecast, month price target, predictions and analyst recommendations. Q3 . View GAAP EPS Projections Surprise. Profile. MORE. Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to. The 63 analysts offering price forecasts for Gilead Sciences have a median target of , with a high estimate of and a low estimate of View Gilead Sciences, Inc. GILD stock quote prices, financial information, real-time forecasts, and company news from CNN.
The Projections were not provided to Gilead (other than selected Gilead Sciences, Inc. , , Kite Pharma, Inc. , . x. . GlaxoSmithKline plc. Chief Medical Officer Merdad Parsey to Leave Gilead Early FOSTER CITY, Calif(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today. Estimated quarterly earnings by December 31, Price Target. The average one-year price target for Gilead Sciences, Inc. is $ Forecast Spread, 27 26 %, 27 26 %, 27 27 Q1. Q2. Q3. Q4. Net sales. Million USD, Released Forecast. Latest Gilead Sciences Inc (GILD:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Gilead Sciences is forecast to grow earnings and revenue by % and % per annum respectively. EPS is expected to grow by % per annum. Return on equity. View Gilead Sciences, Inc. GILD stock quote prices, financial information, real-time forecasts, and company news from CNN. 3 Small-Cap Stocks to Buy and Hold For and Beyond · BJ's Stock Slides Read more about Gilead Sciences' stock forecast and price target. Previous. Last earnings announcement. Aug 8, Reported EPS. Consensus EPS Forecast. EPS. Next Year (). No. of Analysts, 20, 18, 23, Avg. Estimate, , , , Low Estimate, , , , High Estimate, , , Gilead Sciences Inc. (GILD) Stock Price Prediction, Stock Forecast for next months and years ; April , Open: , Close: ; May , Open:
as Chief Medical Officer, Effective Early Jul Gilead Sciences, Inc Gilead Sciences: Realizing Financial Projections Is Key. Mar Gilead. Gilead Sciences (GILD) stock price prediction is USD. The Gilead Sciences stock forecast is USD for August Gilead Sciences, Inc. Stock Price Forecast for January , Open: , Close: , Min: , Max: , Change: % △. February , Open. EPS Growth Forecast. Unlock. Next Earnings Date: Nov 06, Dividend (Yield) This has 40% upside by January Hold. Do not sell. Reply 5 0. Luis. Based on the Rule 16, the options market is currently suggesting that Gilead Sciences will have an average daily up or down price movement of about % per. Dividend Summary ; Forecast, Quarterly, 07 Aug , 15 Sep , ; Forecast, Quarterly, 24 Apr , 13 Jun , 27 Jun Over the next 52 weeks, Gilead Sciences has on average historically risen by % based on the past 32 years of stock performance. · Gilead Sciences has risen. Analyst Estimates: More Content: Snapshot, Stock Price Targets, Yearly Numbers, GILD will report earnings on 02/11/ Based on 20 Wall Street analysts who have issued ratings for Gilead Sciences in the last 12 months, the stock has a consensus rating of "Hold.
View Align Technology, Inc. ALGN stock quote prices, financial information, real-time forecasts, and company news from CNN. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the last. Forecasts Income Statement Balance Sheet Cash flow Financial Ratios *. Net sales, B, B. Net income, M, B. Net Debt, B, B. Jefferies raised its price target on Gilead Sciences, Inc. to $95 from $90, keeping a Buy rating. Analysts report an average outperform rating, with price. Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Gilead Sciences is 'Strong Buy'.
The average one-year price target for Gilead Sciences, Inc. is GBX. The forecasts range from a low of GBX to a high of GBX. A stock's price. EV/EBITDA(e) , EV/EBITDA NTM. Gilead Sciences Inc. Free trial · Free This is a Forecast CAGR (Compound Annual Growth Rate) of Net Sales Estimates.